The brief · 4 June 2026
Two pharma heavyweights are betting big on AI-designed antibodies, the Mayo Clinic is sharpening its brain tumor diagnostics, and NVIDIA just dropped an open 550-billion-parameter model. Meanwhile, Washington and London are moving at opposite speeds on regulation.
Chai Discovery trains a model that designs therapeutic antibodies, not just predicts existing structures. Two pharma heavyweights are signing partnerships to test it on their own pipelines. If it works, antibody design shifts from wet lab to computation.
practitioners › Chai Discovery is reportedly in talks to raise $400M at a $3.4B valuation, following deals with Pfizer and Eli Lilly on antibody discovery.
Forbes →Meningiomas account for nearly 40% of central nervous system tumors, and treatment decisions often hinge on imprecise classification. An algorithm trained on almost 1,700 patient records could sharpen that classification and help guide more targeted care, ranging from watchful waiting to surgery.
practitioners › Nearly 1,700 Mayo Clinic patient records were used to train the model, aiming to reclassify meningiomas and refine treatment decisions.
Mayo Clinic →This model targets long-horizon agentic tasks, the kind where AI has to chain steps together for hours without losing track. NVIDIA is releasing the weights, training data, and recipes, not just a closed API. For developers building agents, that means a serious starting point without getting locked into a single vendor.
practitioners › Mixture-of-Experts architecture, 550B parameters, open weights and data since June 4, 2026.
NVIDIA →Until now, ChatGPT's memory just piled up outdated info with no spring cleaning. Dreaming V3 runs in the background to keep what's still relevant and ditch the rest, so responses should better match your current situation.
practitioners › Rolling out June 4, 2026 for Plus/Pro accounts in the US, nothing to activate.
OpenAI →A Republican and a Democrat have finally put forward a joint federal AI bill, after months of states going their own way. The trade-off: Washington takes over model safety and workforce-impact rules, while states like Illinois and Connecticut pause their own laws for three years. Awkward timing for states that just passed theirs.
practitioners › 269-page draft, filed June 4, 2026 by Jay Obernolte (R-CA) and Lori Trahan (D-MA), includes a three-year state-law preemption clause.
obernolte.house.gov →The UK has been regulating AI sector-by-sector for years, with no single overarching statute. This debate tests whether the government is ready to shift approach, just as the EU and several US states already have their own frameworks in place.
practitioners › Question for Short Debate in the House of Lords, 4 June 2026, no bill tabled yet.
UK Parliament →